TABLE 3

Pharmacokinetic parameters of M7 after an intravenous administration of 15 mg/kg M7 to control (n = 9) and 5/6 Nx (n = 13) rats

Data are expressed as mean ± S.D.

ParameterControl rats (n = 9)5/6 Nx rats (n = 13)
Cmax (μg/ml)24.7 ± 6.451.9 ± 7.4a
tmax (h)0.08 ± 0.000.08 ± 0.00
t1/2 (h)0.27 ± 0.050.93 ± 0.29a
AUC0–t (μg·h/ml)7.83 ± 1.7128.3 ± 6.9a
AUC0–∞ (μg·h/ml)7.87 ± 1.7128.5 ± 6.9a
CL (l/h/kg)1.98 ± 0.410.55 ± 0.11a
Vss (l/kg)0.40 ± 0.150.33 ± 0.08
MRT (h)0.20 ± 0.050.61 ± 0.17a
  • AUC0–∞, area under the concentration-time curve from 0 hour to the infinite time; CL, total body clearance; Cmax, maximum plasma concentration; tmax, time to the Cmax; t1/2, apparent elimination half-life; MRT, mean residence time; VSS, volume of distribution at steady state.

  • a P < 0.001 compared with control.